Ticker: JAZZ

Company: JAZZ PHARMACEUTICALS INC

Person: Seamus Mulligan, director

Transaction date: May 9, 2025

Reporting date: May 13, 2025

Average share price: 98.336777897285

Bought 101621.0 shares for 9993081.71